Bilateral or Generalized Leucoderma can begin at any age and tends to progress intermittently over the life of the patient. It produces depigmentation which is remarkably symmytrical in distribution. A patch on the right side of the body is matched by a patch in a similar location on the left side of the body. The entire body can depigment although it rarely does so.
2).Unil ateral (or Segmental):
Unilateral or Seg mental Leucoderma co mmonly begins in childrens and young adults and progresses for a limited period, usually 1-2 years, and then remains static for the rest of the life of the individual. It affects just one side of the body contrast to Bilateral Leucoderma, the distribution is asymmetrical on the skin.
MELANIN PIGMENT:
Melanins are polymorphous and multifunctional biopolymers. It includes eumelanin, pheomelanin, neuromelan in and mixed melan in pig ment (shown in figure 1 ) 10 .
Intact mature melanosomes pass from basal melanocytes into keratinocytes and their lysosomal compart ment to become melanin dust in the upper nonviable layers of the skin 11 . Melanin is synthesized by melanocytes within melanosomes that are transferred into the surrounding keratinocytes 12 . The keratinocytes transport the melanin and melanosomes from the basal layer of the epidermis to the stratum corneu m where they are desquamated into the environment (as shown in figure. 2) 13 .
PATHOPHYS IOLOGY OF LEUCODERMA:
There are two basic mechanisms whereby the skin can become white 14 . Some disorders inhibit or retard the production of melan in formation and the skin develops hypopigmentation 15 . Such disorders include, among many others, oculocutaneous albinism, pityriasis alba, tinea vesicolor and nevus depigmentosus 16 . In these disorders, melanocytes are present in normal nu mbers in the epidermis but produce less than normal amounts of melanin. Typically the skin exhib its mild to marked hypopigmentation.
In contrast, other types of leucoderma are characterized by the absence of melanocytes and therefore, complete absence of melan in. Such d isorders include piebaldis m, the leucoderma of lupus erythematosus and other scarring disorders and vitiligo. These types of leucoderma typically are totally depigmented. Vitiligo and lupus cause a destruction of melanocytes during postnatal life. Piebald ism affects the migration of melanocytes during embryogenesis and the infant is born with depig menattion of the hair and skin. The et iology of leucoderma is poorly understood. Various factors (stress, trauma, exposure to sunlight, infections, malignancies, neural abnormalit ies, melatonin, receptor dysfunction, impaired melanocyte migrat ion, some drugs, endocrine disease and cytotoxic compounds) have been implicated in the development of leucoderma. Despite these various factors the exact cause of leucoderma remains unclear. Many theories 17 (biochemical theory, cytotoxic theory, oxidant-antioxidant theory, neural theory, viral theory, autoimmune theory, self destruct theory, growth factor theory and convergence theory) have been proposed to explain this disorder along with factors (as shown in table 1). 
TREATMENT AVAILAB LE FOR LEUCODERMA:
In general topical monotherapy is indicated for mild to moderate vitiligo 23, 24 . Current treatment options for vitiligo include med ical, surgical and additional treatments 25, 26 . Medical treat ment targets the immune system and helps to arrest the spread of depigmentation 27, 28 . In cases of stable vitiligo, repig mentation can be achieved by dermatosurgical techniques and additional includes use of cosmetics 29, 30 . Both surgical and med ical t reatment have their own limitations. Additional can only cover the patch and can be used along with surgical and medical treatments 31 .
A).Medical Therapies 1).Topical Steroi d Therapy:
Topical steroids are useful for the treatment of localized leucoderma. Marked or almost complete repig mentation can be obtained with potent corticosteroids (betamethasone, valerate, triamcinolone) and very potent corticosteroids (clobetasol, fluticasone propionate).
2).Psoralen Photochemotherapy a).Topical Psoralen Photochemotherapy:
Topical PUVA (Psoralen Plus UltraVio let light A) includes lower cumulat ive UVA doses than oral PUVA and lack of ocular and systemic to xicity. Low concentrations of psoralens should be used. The patient should be exposed to UVA approximately 20 to 30 minutes after application of the topical preparation. Following treatment the area is washed, a broad-spectrum sunscreen is applied and excessive sun exposure is avoided for at least 24 hours. b).Oral Psoralen Photochemotherapy: Oral PUVA involves the admin istration of psoralens orally followed by exposure to long-wavelength UVA irradiat ion.
3).Depig mentation:
Dep ig mentation is a more drastic form of treatment, when leucoderma is extensive i.e. leucoderma universalis. Depig mentation involves fading the rest of the skin on the body to match the already white areas by using permanent melanocytotoxic agents such as Monobenzyl ester of hydroquinone cream (Benzoquin), 4-metho xyphenol (4-MP).
B).Surgical Therapies 1).Autologous Skin Grafts:
In this technique grafts are implanted into perforations prepared at the recipient sites. Pig ment spread leading to repigmentation can be stimulated by phototherapies.
2).Skin Grafts Using Blisters :
In this technique blisters can be induced by different ways such as vacuum or liquid nitrogen. The mechanical split occurs at the dermoepidermal junction. The recipient site is prepared by dermabrasion. The graft is applied and secured on the recipient site.
3)Micropig mentation (Tattooing):
In this technique permanent dermal micropig mentation is done by using a nonallergic iron o xide pig ment to camouflage recalcitrant areas of leucoderma. C).Additional Therapies 1).Sunscreen: Leucodermic skin is more susceptible to sunburn and long term photodamage. To prevent suninduced darkening of the surrounding normal skin, broad spectrum high protection factor sunscreens (SPF [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] ) which provide protection fro m UVB and UVA light should be used.
2).Cosmetic: Camouflage is often used to cover affected areas. This may be practical for patients that have minimal disease or segmental disease.
NATURAL FURANOCOUMARINS AS TREATMENT FOR LEUCODERMA:
Psoralens belong to a group of heterocyclic compounds, the furanocoumarins, which are found in four or five major plant families. The umbelliferae and rutacae are the largest and most important of these; the leguminosae and moraceae include few but widely distributed species. Chemical structures of Psoralen and Isopsoralen are described (as shown in the figure. 3) 59 Psoralen Isopsoralen Many familiar edible plants as celery, figs, caraway, lemon, etc., contain psoralens. As such, psoralens are components, in normal d iet, and they may even play a role in the physiology and biochemistry of normal hu man skin. It is of interest to mention that psoralens are found in many herbal remedies that have been employed for centuries 32, 33 . Furanocoumarins are synthesized when the furan ring is built on a suitably substituted coumarin derivative. A furan ring can be condensed with a coumarin mo lecule in 12 different ways and each of the resulting compounds can become the parent of a family of psoralen-like derivatives. Only those with a linear tricyclic structure resembling that of psoralen are active, potent photosensitizers. Those with a non-linear structure (angular nodes) like that of isopsoralen and iso-pseudo-psoralen are inactive 34, 35 . The mechanis m of repig mentation of leucoderma patches under psoralen therapy cannot be clearly defined in the light of the available knowledge of the cause of leucoderma. However, it may be justifiab le to suggest that one or more of the following mechanis ms may operate in the process of repig mentation of leucoderma 36,37 :
1). Through the increased tolerance to sun, and ultraviolet rays psoralens permit much longer solar or ultraviolet light irradiation and thus allow stronger stimu lation to th e melanocytes.
2). Dopa positive melanocytes have been claimed to be present in the so-called relative leucoderma. Repig mentation may occur in areas having melanocytes that still retain, although slightly, dopa positively but not in areas having no dopa positive melanocytes. Psoralens may bring about stimu lation of these weak dopa positive melanocytes to be actively engaged in melanogenesis.
3). Psoralens may induce migrat ion of active melanocytes fro m the surrounding normal epidermis or hair melanocytes, lead to colonization of the depigmented areas by the melanocytes of the pigmented hair bulb. 4). Psoralens may correct the ultrastructural abnormalit ies of the leucoderma melanocytes. 
CONCLUS ION:
Furanocoumarins are biologically active natural compounds found main ly in p lants belonging to the Umbelliferae, Rutaceae, Apiaceae, Asteraceae, Fabaceae, Oleaceae, Moraceae, Thymeleaceae Families. Furanocoumarins forms monofunctional adducts which would less likely pro mote cutaneous malignancies as compared to bifunctional adduct. The application of psoralens and different derivatives of psoralens with potentially fewer acute side effects has been one of the most recent advancements in the treatment of leucoderma. Psoralen containing plants have been used for centuries in popular medicine to treat leucoderma, a skin disease characterized by lack of pig mentation. Further advancement in treatments using different derivatives of psoralen molecu les should strive to decrease the possibility of long term side effects such as cutaneous malignancies.
